Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.

Sub-classes under this class:

Class Number	Class Name	Patents
514/236.5	The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)	203
514/236.2	Three or more ring hetero atoms in the additional hetero ring	342

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
6949544	Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases	Sep. 27, 2005
6939872	2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors	Sep. 6, 2005
6936607	2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety	Aug. 30, 2005
6936616	Pyrimidine matrix metalloproteinase inhibitors	Aug. 30, 2005
6930093	Use of ribofuranose derivatives against inflammatory bowel diseases	Aug. 16, 2005
6924278	Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists	Aug. 2, 2005
6916797	.alpha.-arylethylpiperazine derivatives as neurokinin antagonists	Jul. 12, 2005
6916804	Pyrimidine A2b selective antagonist compounds, their synthesis and use	Jul. 12, 2005
6916812	Alpha-aminoamide derivatives as melanocortin agonists	Jul. 12, 2005
6916813	(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase	Jul. 12, 2005
6908920	Pyrimidine derivatives	Jun. 21, 2005
6908919	Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade	Jun. 21, 2005
6906065	4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases	Jun. 14, 2005
6894041	Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes	May. 17, 2005
6890925	Methods of using soluble epoxide hydrolase inhibitors	May. 10, 2005
6887870	Heterocyclic sodium/proton exchange inhibitors and method	May. 3, 2005
6884804	Inhibitors of Src and other protein kinases	Apr. 26, 2005
6884801	Imidazoline derivatives as alpha-1A adrenoceptor ligands	Apr. 26, 2005
6881736	Vitronectin receptor antagonists	Apr. 19, 2005
6875764	Urea and thiourea compounds useful for treatment of coccidiosis	Apr. 5, 2005
6872741	Sodium channel modulators	Mar. 29, 2005
6869945	Pyrrolyl-and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes	Mar. 22, 2005
6867209	Indole-type derivatives as inhibitors of p38 kinase	Mar. 15, 2005
6867205	Pyridine and pyrimidine derivatives	Mar. 15, 2005
6864276	Active substance combinations having insecticidal and acaricidal properties	Mar. 8, 2005
6864254	Inhibitor for 20-hete-yielding enzyme	Mar. 8, 2005
6861442	PYK2 and inflammation	Mar. 1, 2005
6861425	Benzimidazole compounds as ORL1-receptor agonists	Mar. 1, 2005
6852718	Phenylsulphonylipiperazinyl derivatives as 5-HT receptor ligands	Feb. 8, 2005
6852717	Compounds useful as anti-inflammatory agents	Feb. 8, 2005
6849622	Aliphatic nitrogenous five-membered ring compounds	Feb. 1, 2005
6844347	Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same	Jan. 18, 2005
6833364	Substituted pyrazole derivatives	Dec. 21, 2004
6833372	Non-peptide GnRH agents, Pharmaceutical compositions, and methods for their use	Dec. 21, 2004
6825228	Benzothiophene compounds having antiinfective activity	Nov. 30, 2004
6825190	Protein kinase inhibitors and uses thereof	Nov. 30, 2004
6821971	Fused pyrazolone compounds which inhibit the release of inflammatory cytokines	Nov. 23, 2004
6821965	Amidobenzamide derivatives which are useful as cytokine inhibitors	Nov. 23, 2004
6794386	.beta.-amino acid compounds as integrin antagonists	Sep. 21, 2004
6787542	Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents	Sep. 7, 2004
6784173	Aromatic dicarboxylic acid derivatives	Aug. 31, 2004
6759424	Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them	Jul. 6, 2004
6756380	5-phenyl-pyrimidine derivatives	Jun. 29, 2004
6756377	Compounds and their use	Jun. 29, 2004
6756374	Diaminothiazoles having antiproliferative activity	Jun. 29, 2004
6753327	Substituted amides, their preparation and use	Jun. 22, 2004
6743792	6-azauracil derivatives as IL-5 inhibitors	Jun. 1, 2004
6743798	Substituted pyrazole derivatives condensed with six-membered heterocyclic rings	Jun. 1, 2004
6743791	Heterocyclic inhibitors of ERK2 and uses thereof	Jun. 1, 2004
6743788	Carbamate and oxamide compounds	Jun. 1, 2004